Inventor · disambiguated record
Chundao Yang
Also filed as: YANG CHUNDAO
17 granted patents·6 pending applications·15 citations·filing 2012–2023
87Inventor score
Files withMEDSHINE DISCOVERY INC6MERCK SHARP & DOHME6WUXI BIOCITY BIOPHARMACEUTICS CO LTD3LIU JIAN2SHIJIAZHUANG SAGACITY NEW DRUG DEV CO LTD2
Top patents by PatentIndex Score
23 records- 0186US9718828B2BTK InhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Aug 1, 2017·7 cites·15 claims
- 0280US11613545B2Macrocyclic compound serving as Wee1 inhibitor and applications thereofWUXI BIOCITY BIOPHARMACEUTICS CO LTD·Filed 2018·Granted Mar 28, 2023·2 cites·20 claims
- 0372US9481682B2Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Nov 1, 2016·2 cites·23 claims
- 0471US10662189B2PDE4 inhibitorSHIJIAZHUANG SAGACITY NEW DRUG DEV CO LTD·Filed 2017·Granted May 26, 2020·1 cites·31 claims
- 0571US10532986B2Cyclic compound acting as PDE4 inhibitorMEDSHINE DISCOVERY INC·Filed 2017·Granted Jan 14, 2020·1 cites·24 claims
- 0666US10087188B2Benzamide imidazopyrazine Btk inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 2, 2018·1 cites·2 claims
- 0765US9446130B2BTK inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Sep 20, 2016·1 cites·18 claims
- 0859US2024376093A1Sulfoximine compound and use thereofMEDSHINE DISCOVERY INC·Filed 2022·Application pending·0 cites
- 0957US2025188077A1Crystal form of 1h-pyrrolo[2,3-c]pyridine compound and preparation method thereforJUMBO DRUG BANK CO LTD·Filed 2023·Application pending·0 cites
- 1056US2024043419A1Class of 1,7-naphthyridine compounds and application thereofMEDSHINE DISCOVERY INC·Filed 2021·Application pending·0 cites
- 1148US11384065B2Heterocyclic compound as CSF-1R inhibitor and use thereofMEDSHINE DISCOVERY INC·Filed 2019·Granted Jul 12, 2022·0 cites·19 claims
- 1248US11230549B2Quinolino-pyrrolidin-2-one derivative and application thereofMEDSHINE DISCOVERY INC·Filed 2019·Granted Jan 25, 2022·0 cites·22 claims
- 1346US11299475B2Prostacyclin receptor agonistMEDSHINE DISCOVERY INC·Filed 2019·Granted Apr 12, 2022·0 cites·20 claims
- 1445US12180184B2Pyrimidopyrazolone derivative as Wee1 inhibitor and use thereofWUXI BIOCITY BIOPHARMACEUTICS CO LTD·Filed 2019·Granted Dec 31, 2024·0 cites·22 claims
- 1544US12291536B2Crystal form of Wee1 inhibitor compound and use thereofWUXI BIOCITY BIOPHARMACEUTICS CO LTD·Filed 2020·Granted May 6, 2025·0 cites·28 claims
- 1644US2014221333A1Btk inhibitorsDE MAN ADRIANUS PETRUS ANTONIUS·Filed 2012·Application pending·0 cites
- 1740US10954253B21,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one derivative as Wee1 inhibitorSHIJIAZHUANG SAGACITY NEW DRUG DEV CO LTD·Filed 2018·Granted Mar 23, 2021·0 cites·19 claims
- 1839US2021338665A1Medical use of prostacyclin receptor agonistCHINESE PLA GENERAL HOSPITAL·Filed 2019·Application pending·0 cites
- 1937US10208047B2Tertiary alcohol imidazopyrazine BTK inhibitorsLIU JIAN·Filed 2015·Granted Feb 19, 2019·0 cites·8 claims
- 2036US10214546B2Btk inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Feb 26, 2019·0 cites·7 claims
- 2136US10130630B2BTK inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Nov 20, 2018·0 cites·5 claims
- 2236US2018141962A1Azacarbazole btk inhibitorsLIU JIAN·Filed 2016·Application pending·0 cites
- 2320US10017507B2Diaza-benzofluoranthrene compoundsHARBIN PHARMACEUTICAL GROUP CO LTD GENERAL PHARMACEUTICAL FACTORY·Filed 2016·Granted Jul 10, 2018·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Chundao Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →